1. Home
  2. IIIN vs RZLT Comparison

IIIN vs RZLT Comparison

Compare IIIN & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

IIIN

Insteel Industries Inc.

N/A

Current Price

$32.34

Market Cap

484.9M

Sector

Industrials

ML Signal

N/A

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

N/A

Current Price

$4.63

Market Cap

420.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IIIN
RZLT
Founded
1953
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
484.9M
420.8M
IPO Year
1994
2011

Fundamental Metrics

Financial Performance
Metric
IIIN
RZLT
Price
$32.34
$4.63
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$9.67
AVG Volume (30 Days)
266.8K
1.2M
Earning Date
04-16-2026
05-13-2026
Dividend Yield
4.37%
N/A
EPS Growth
112.12
26.32
EPS
1.12
N/A
Revenue
$647,706,000.00
N/A
Revenue This Year
$14.20
N/A
Revenue Next Year
$6.82
N/A
P/E Ratio
$29.30
N/A
Revenue Growth
22.39
N/A
52 Week Low
$24.35
$1.07
52 Week High
$39.91
$11.46

Technical Indicators

Market Signals
Indicator
IIIN
RZLT
Relative Strength Index (RSI) 57.75 47.97
Support Level $30.35 $4.51
Resistance Level $33.17 $4.71
Average True Range (ATR) 0.93 0.27
MACD -0.01 -0.04
Stochastic Oscillator 62.38 22.30

Price Performance

Historical Comparison
IIIN
RZLT

About IIIN Insteel Industries Inc.

Insteel Industries Inc produces and sells prestressed concrete strand (PC strand) and welded wire reinforcement (WWR). PC strand, a high-strength seven-wire cable, is used to strengthen precast concrete in structures like bridges, parking decks, and buildings, enabling longer spans and slimmer designs. WWR includes engineered structural mesh for primary reinforcement, concrete pipe reinforcement for drainage and sewage systems, and standard WWR for crack control in residential and light commercial construction. The company serves markets in the United States and internationally, with the majority of revenue generated in the United States.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: